Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis

ConclusionThis meta-analysis with TSA found no evidence of an association of isotretinoin use with IBD. Isotretinoin should not be withheld because of unnecessary concerns for the development of IBD.PROSPERO registration noCRD42022298886.
Source: American Journal of Clinical Dermatology - Category: Dermatology Source Type: research